Avadel Pharmaceuticals (AVDL) Operating Margin: 2009-2020
Historic Operating Margin for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2020 value amounting to 26.04%.
- Avadel Pharmaceuticals' Operating Margin rose 49790.00% to 431.08% in Q4 2020 from the same period last year, while for Dec 2020 it was 36.88%, marking a year-over-year increase of 7760.00%. This contributed to the annual value of 26.04% for FY2020, which is 6676.00% up from last year.
- Avadel Pharmaceuticals' Operating Margin amounted to 26.04% in FY2020, which was up 163.94% from -40.72% recorded in FY2019.
- In the past 5 years, Avadel Pharmaceuticals' Operating Margin ranged from a high of 51.66% in FY2017 and a low of -101.60% during FY2018.
- For the 3-year period, Avadel Pharmaceuticals' Operating Margin averaged around -38.76%, with its median value being -40.72% (2019).
- Per our database at Business Quant, Avadel Pharmaceuticals' Operating Margin plummeted by 15,327bps in 2018 and then surged by 6,676bps in 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Operating Margin (Yearly) stood at -3.30% in 2016, then surged by 5,497bps to 51.66% in 2017, then plummeted by 15,327bps to -101.60% in 2018, then spiked by 6,089bps to -40.72% in 2019, then skyrocketed by 6,676bps to 26.04% in 2020.